STAT3: A Promising Therapeutic Target in Multiple Myeloma
Multiple myeloma (MM) is an incurable plasma cell malignancy for which novel treatment options are required. Signal Transducer and Activator of Transcription 3 (STAT3) overexpression in MM appears to be mediated by a variety of factors including interleukin-6 signaling and downregulation of Src homo...
Main Authors: | Phyllis S. Y. Chong, Wee-Joo Chng, Sanjay de Mel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/731 |
Similar Items
-
Targeting Aberrant STAT3 Signaling as a Therapeutic Strategy for Multiple Myeloma
by: Croucher, Danielle
Published: (2013) -
Targeting Aberrant STAT3 Signaling as a Therapeutic Strategy for Multiple Myeloma
by: Croucher, Danielle
Published: (2013) -
Targeting NF-kB Signaling for Multiple Myeloma
by: Ada Hang-Heng Wong, et al.
Published: (2020-08-01) -
Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma
by: Min Hee Yang, et al.
Published: (2019-12-01) -
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
by: Rosemarie Tremblay-LeMay, et al.
Published: (2018-12-01)